British-Based Abingdon Health USA Expands Madison, Wisconsin, Operations

Area Development News Desk

06/04/2026

Medical diagnostics manufacturer Abingdon Health USA plans to expand its operations in Madison, Wisconsin. The more than $1.8 million project is expected to create 46 jobs.

The company’s new manufacturing facility will be designed to support increasing growth in demand for lateral flow diagnostic products and provide U.S. customers with development, manufacturing, and regulatory support services.

“We are grateful for this award from the Wisconsin Economic Development Corporation, which serves as a welcome endorsement of our commitment and investment in Wisconsin and our positioning in the U.S. market,” said Chris Yates, President of Abingdon Health USA. “These tax credits will support our expansion at University Research Park in Madison, including the creation of additional skilled roles as Abingdon Health USA continues to grow to meet customer demand across the United States.”

To support the project, the Wisconsin Economic Development Corporation (WEDC) authorized up to $370,000 in performance-based state income tax credits. The amount of credits the company ultimately receives will depend on job creation and capital investment levels.

“Abingdon’s decision to locate in Wisconsin and continue to grow here reflects the strength of our state’s leadership in the field of biohealth and biotechnology, our outstanding research institutions, and our highly trained workforce,” noted John W. Miller, Secretary and CEO of the Wisconsin Economic Development Corporation. “WEDC is proud to partner with Abingdon as they open this next chapter.”

Abingdon Health USA is a diagnostic testing company that develops and manufactures rapid lateral flow tests for healthcare, life sciences, and industrial applications. The company provides product development, manufacturing, and commercialization services for point-of-care diagnostics.

Recent Project Announcements